文献速递衰弱、肌少症与跌倒老年慢病共病管理

衰弱、长期护理院特征与疫苗接种前后COVID-19死亡率的关系

The association between frailty, long-term care home characteristics and COVID-19 mortality before and after SARS-CoV-2 vaccination: a retrospective cohort study.
PubMed 文献 · Age Ageing · 2023-01-01

该研究基于加拿大安大略省长期护理院居民的确诊SARS-CoV-2感染回顾性队列,采用多水平多变量logistic回归分析30天COVID-19死亡率与Hubbard衰弱指数及院舍特征的关系。疫苗前和疫苗后分别纳入11,179例和3,655例,30天死亡率分别为25.9%和20.0%;衰弱指数每增加0.1,死亡 odds 在疫苗前为1.49倍(95%CI 1.42-1.56),疫苗后关联保持一致。院舍层面特征未显著解释院际死亡率差异。

要点

  • 衰弱指数每增加0.1,30天COVID-19死亡 odds 在疫苗前为1.49倍(95%CI 1.42-1.56)。
  • 疫苗后衰弱与死亡的关联保持一致,但性别和年龄的关联部分减弱。
  • 所考察的院舍特征均未显著解释院际30天COVID-19死亡率差异。

核心结论

  • 衰弱在SARS-CoV-2疫苗接种前后均与长期护理院居民30天COVID-19死亡率 consistently 相关。
  • 既往归因于COVID-19结局的院舍特征不能解释显著的院际死亡率差异。

研究设计与样本

  • 基于加拿大安大略省长期护理院确诊SARS-CoV-2感染居民的人群回顾性队列研究。
  • 采用多水平多变量logistic回归分析30天COVID-19死亡率与Hubbard衰弱指数及居民和院舍特征的关系。
  • 比较疫苗可用前和疫苗可用后的解释模型。

主要发现

  • 疫苗前和疫苗后分别有11,179例和3,655例COVID-19病例,30天COVID-19死亡率分别为25.9%和20.0%。
  • 30天COVID-19死亡率的院际中位 odds ratio 在疫苗前为1.50(95%CrI 1.41-1.65),疫苗后为1.62(95%CrI 1.46-1.96)。
  • 疫苗前,男性和年龄较大者30天COVID-19死亡率更高;Hubbard衰弱指数每增加0.1,死亡 odds 为1.49倍(95%CI 1.42-1.56)。
  • 疫苗后衰弱与死亡的关联保持一致,但性别和年龄的关联部分减弱。
  • 尽管存在显著的院际变异,所考察的院舍特征在任一时期均未与30天COVID-19死亡率显著相关。

关键数值与推荐

  • Hubbard衰弱指数每增加0.1,疫苗前30天COVID-19死亡 odds ratio 为1.49(95%CI 1.42-1.56)。
  • 院际30天COVID-19死亡率中位 odds ratio 疫苗前为1.50(95%CrI 1.41-1.65),疫苗后为1.62(95%CrI 1.46-1.96)。

临床怎么用

  • 在长期护理院中,应重视衰弱评估以识别COVID-19死亡高风险居民,疫苗前后均适用。
  • 院舍层面特征不能充分解释院际COVID-19死亡率差异,需关注居民个体因素如衰弱。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The relative contributions of long-term care (LTC) resident frailty and home-level characteristics on COVID-19 mortality has not been well studied. We examined the association between resident frailty and home-level characteristics with 30-day COVID-19 mortality before and after the availability of SARS-CoV-2 vaccination in LTC. METHODS: We conducted a population-based retrospective cohort study of LTC residents with confirmed SARS-CoV-2 infection in Ontario, Canada. We used multi-level multivariable logistic regression to examine associations between 30-day COVID-19 mortality, the Hubbard Frailty Index (FI), and resident and home-level characteristics. We compared explanatory models before and after vaccine availability. RESULTS: There were 11,179 and 3,655 COVID-19 cases in the pre- and post-vaccine period, respectively. The 30-day COVID-19 mortality was 25.9 and 20.0% during the same periods. The median odds ratios for 30-day COVID-19 mortality between LTC homes were 1.50 (95% credible interval [CrI]: 1.41-1.65) and 1.62 (95% CrI: 1.46-1.96), respectively. In the pre-vaccine period, 30-day COVID-19 mortality was higher for males and those of greater age. For every 0.1 increase in the Hubbard FI, the odds of death were 1.49 (95% CI: 1.42-1.56) times higher. The association between frailty and mortality remained consistent in the post-vaccine period, but sex and age were partly attenuated. Despite the substantial home-level variation, no home-level characteristic examined was significantly associated with 30-day COVID-19 mortality during either period. INTERPRETATION: Frailty is consistently associated with COVID-19 mortality before and after the availability of SARS-CoV-2 vaccination. Home-level characteristics previously attributed to COVID-19 outcomes do not explain significant home-to-home variation in COVID-19 mortality.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Dash D, Mowbray FI, Poss JW, et al. The association between frailty, long-term care home characteristics and COVID-19 mortality before and after SARS-CoV-2 vaccination: a retrospective cohort study. Age Ageing. 2023. PMID: 38163287. doi:10.1093/ageing/afad229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。